Gts Securities LLC Moderna, Inc. Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $11.2 Million - $22 Million	175,900 Added 71.77%	421,000 $28.1 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $5.94 Million - $9.78 Million	-58,700 Reduced 19.32%	245,100 $29.1 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $8.5 Million - $11.5 Million	-99,600 Reduced 24.69%	303,800 $32.4 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $1.12 Million - $1.68 Million	-16,100 Reduced 3.84%	403,400 $40.1 Million
Q3 2023 Nov 15, 2023	BUY	$96.41 - $126.61 $40.4 Million - $53.1 Million	419,500 New	419,500 $43.3 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.